Description
The present invention relates to pharmaceutical compositions based on antiinflammatory active ingredients and to the use thereof for the treatment of rheumatoid diseases. The compositions comprise lactalbumin hydrolysate or a fraction thereof. Substantially lower doses of the antiinflammatory drugs are thus possible than is conventionally necessary to achieve a particular antiinflammatory effect.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Official Data Source | HTML | Access the complete Patent AT-E400286-T1: [Translated] PHARMACEUTICAL PRODUCT CONTAINING AN ANTIPHLOGISTIC ACTIVE INGREDIENT AND LACTALBUMIN HYDROLYZATE AND USE THEREOF on the official website. | Open resource |